A new strategy to design label-free electrochemical biosensor for ultrasensitive diagnosis of CYFRA 21-1 as a biomarker for detection of non-small cell lung cancer

被引:50
|
作者
Jafari-Kashi, Abbas [1 ]
Rafiee-Pour, Hossain-Ali [2 ]
Shabani-Nooshabadi, Mehdi [1 ,3 ]
机构
[1] Univ Kashan, Fac Chem, Dept Analyt Chem, Kashan, Iran
[2] Univ Kashan, Fac Chem, Dept Cell & Mol Biol, Kashan, Iran
[3] Univ Kashan, Inst Nano Sci & Nano Technol, Kashan, Iran
关键词
CYFRA21-1; Electrochemical biosensor; Lung cancer; Guanine oxidation; Label-free; COMPOSITE THIN-FILM; GRAPHENE OXIDE; DNA BIOSENSOR; NANOPARTICLES; FABRICATION; MARKER; ASSAY;
D O I
10.1016/j.chemosphere.2022.134636
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Lung cancer is one of the most dangerous cancers with high mortality rate among other cancers therefore, early detection of this cancer is very important. Many studies have been reported in ways of diagnostic lung cancer early. According to reports, one of the most important biomarkers to detect lung cancer is Cytokeratin 19 fragment 21-1 (CYFRA21-1), which is significantly related to non-small cell lung cancer, in particular, squamous cell carcinoma. Thus, finding a new method for the early diagnosis of CYFRA 21-1 (DNA target probe) is essential. In the present report, we design a novel label-free electrochemical DNA-biosensor related to the signal of guanine oxidation. The proposed DNA biosensor is fabricated by a modified glassy carbon electrode (GCE) with reduced-graphene oxide (rGO), poly pyrrole (PPy), silver nanoparticles (AgNPs) and single-strand DNA (ssDNA as capture probe) GCE/rGO/PPy/AgNPs/ssDNA. The differential pulse voltammetry (DPV) and cyclic voltammetry (CV) techniques are used to verify the hybridization process between capture and target probes. Electrochemical impedance spectroscopy (EIS), energy diffraction X-ray (EDX) and field-emission scanning microscopy (FE-SEM) techniques are applied to the characterization of different modified GCE surfaces as well as Xray diffraction (XRD) for graphene oxide synthesis. The XRD pattern of the synthesized GO that its diffraction peak appears at 10.2. The applied CV and DPV for the guanine oxidation are determined under optimal conditions. The label-free DNA biosensor showed a great result for the determination of CYFRA21-1 with a wide linear range from two consecutive linear relationships of peak current and CYFRA21-1 concentration were found(1.0 x 10(-14) -1.0 x 10(-10) M, R-2 = 0.9936 and 1.0 x 10(-9) -1.0 x 10(-6) M, R-2 = 0.9955). Proposed electrochemical biosensor displayed low detection limit (2.4 fM).
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Label-free Electrochemical Impedance Spectroscopy Aptasensor for Ultrasensitive Detection of Lung Cancer Biomarker Carcinoembryonic Antigen
    Wang, Yawei
    Chen, Lei
    Xuan, Tiantian
    Wang, Jian
    Wang, Xiuwen
    FRONTIERS IN CHEMISTRY, 2021, 9
  • [22] Novel Ratiometric Electrochemical Biosensor for Determination of Cytokeratin 19 Fragment Antigen 21-1 (Cyfra-21-1) as a Lung Cancer Biomarker
    Wang, Jiajia
    Yang, Xiaomin
    Hua, Xin
    Li, Yanan
    Jin, Baokang
    ANALYTICAL LETTERS, 2023, 56 (17) : 2708 - 2724
  • [23] Label-free real-time ultrasensitive monitoring of non-small cell lung cancer cell interaction with drugs
    Dai, Hailang
    Jiao, Yihang
    Sun, Zhangchi
    Cao, Zhuangqi
    Chen, Xianfeng
    BIOMEDICAL OPTICS EXPRESS, 2018, 9 (09): : 4149 - 4161
  • [24] CYFRA 21-1 in the follow-up of inoperable non-small cell lung cancer patients treated with chemotherapy
    Ebert, W
    Muley, T
    ANTICANCER RESEARCH, 1999, 19 (4A) : 2669 - 2672
  • [25] Preoperative CYFRA 21-1 and CEA as Prognostic Factors in Patients with Stage I Non-Small Cell Lung Cancer
    Blankenburg, Florian
    Hatz, Rudolf
    Nagel, Dorothea
    Ankerst, Donna
    Reinmiedl, Judith
    Gruber, Christine
    Seidel, Dietrich
    Stieber, Petra
    TUMOR BIOLOGY, 2008, 29 (04) : 272 - 277
  • [26] Preoperative CYFRA 21-1 and CEA as prognostic factors in patients with stage I non-small cell lung cancer
    Hanagiri, Takeshi
    Sugaya, Masakazu
    Takenaka, Masaru
    Oka, Sohich
    Baba, Tetsuro
    Shigematsu, Yoshiki
    Nagata, Yoshika
    Shimokawa, Hidehiko
    Uramoto, Hidetaka
    Takenoyama, Mitsuhiro
    Yasumoto, Kosei
    Tanaka, Fumihiro
    LUNG CANCER, 2011, 74 (01) : 112 - 117
  • [27] The Diagnostic and Prognostic Value of CSF Cyfra 21-1 in Patients with Leptomeningeal Metastasis of Non-Small Cell Lung Cancer
    Hyun, Jae-Won
    Kim, Su-Hyun
    Hwang, Sang-Hyun
    Gwak, Ho-Shin
    Kim, Ho Jin
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S958 - S959
  • [28] Prognostic value of serum cytokeratin 19 fragments (Cyfra 21-1) in patients with non-small cell lung cancer
    Youtao Xu
    Lei Xu
    Mantang Qiu
    Jie Wang
    Qing Zhou
    Lin Xu
    Jian Wang
    Rong Yin
    Scientific Reports, 5
  • [29] Prognostic value of serum cytokeratin 19 fragments (Cyfra 21-1) in patients with non-small cell lung cancer
    Xu, Youtao
    Xu, Lei
    Qiu, Mantang
    Wang, Jie
    Zhou, Qing
    Xu, Lin
    Wang, Jian
    Yin, Rong
    SCIENTIFIC REPORTS, 2015, 5
  • [30] Is CYFRA 21-1 and CEA estimation helpful in preoperative assessment of non-small cell lung cancer (NSCLC) patients?
    Monika, Szturmowicz
    Ski, Rudzi P.
    Kacprzak, A.
    Langfort, R.
    Demkow, U.
    Bestry, I
    Orlowski, T.
    TUMOR BIOLOGY, 2006, 27 : 79 - 79